Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Larkin J; Weber J; Del Vecchio M; Gogas H; Arance AM; Dalle S; Cowey CL; Schenker M; Grob JJ; Chiarion-Sileni V; Márquez-Rodas I; Butler MO; Di Giacomo AM; Middleton MR; De la Cruz-Merino L; Arenberger P; Atkinson V; Hill A; Fecher LA; Millward M; Khushalani NI; Queirolo P; Long GV; Lobo M; Askelson M; Ascierto PA; Mandalá M.

Adjuvant nivolumab versus ipilimumab (CheckMate 238 trial): Reassessment of 4-year efficacy outcomes in patients with stage III melanoma per AJCC-8 staging criteria

EUROPEAN JOURNAL OF CANCER. 2022; 173: 285-296 Nº de citas: 32 [doi:10.1016/j.ejca.2022.06.041]

Donat-Vargas, C; Guerrero-Zotano, A; Lope, V; Bermejo, B; Casas, A; Baena-Canada, JM; Antolin, S; Sanchez-Rovira, P; Anton, A; Garcia-Saenz, JA; Ramos, M; Munoz, M; de Juan, A; Sanchez, CJ; Chacon, JI; Gil-Gil, M; Conejero, RA; Llombart, A; Bezares, S; de Larrea-Baz, NF; Perez-Gomez, B; Martin, M; Pollan, M.

Type does matter. Use VIRGIN olive oil as your preferred fat to reduce your risk of breast cancer: case-control EpiGEICAM study

EUROPEAN JOURNAL OF CLINICAL NUTRITION. 2022; 76(9): 1343-1346 Nº de citas: 3 [doi:10.1038/s41430-022-01101-w]

Zhu, Z; Turner, NC; Loi, S; Andre, F; Martin, M; Dieras, V; Gelmon, KA; Harbeck, N; Zhang, C; Cao, JQ; Yan, ZM; Lu, DR; Wei, P; VanArsdale, TL; Rejto, PA; Huang, X; Rugo, HS; Loibl, S; Cristofanilli, M; Finn, RS; Liu, Y.

Comparative biomarker analysis of PALOMA-2/3 trials for palbociclib

npj Precision Oncology. 2022; 6(1): Nº de citas: 23 [doi:10.1038/s41698-022-00297-1]

Siles, MG; Lopez-Beltran, A; Pelechano, P; Vicente, AMG; Sarrio, RG; Pena, EGH; Antolin, AR; Zapatero, A; Arranz, JA; Climent, MA.

Advances in Transversal Topics Applicable to the Care of Bladder Cancer Patients in the Real-World Setting

Cancers. 2022; 14(16): Nº de citas: 2 [doi:10.3390/cancers14163968]

Wysocki, O; Zhou, C; Rogado, J; Huddar, P; Shotton, R; Tivey, A; Albiges, L; Angelakas, A; Arnold, D; Aung, T; Banfill, K; Baxter, M; Barlesi, F; Bayle, A; Besse, B; Bhogal, T; Boyce, H; Britton, F; Calles, A; Castelo-Branco, L; Copson, E; Croitoru, A; Dani, SS; Dickens, E; Eastlake, L; Fitzpatrick, P; Foulon, S; Frederiksen, H; Ganatra, S; Gennatas, S; Glenthoj, A; Gomes, F; Graham, DM; Hague, C; Harrington, K; Harrison, M; Horsley, L; Hoskins, R; Hudson, Z; Jakobsen, LH; Joharatnam-Hogan, N; Khan, S; Khan, UT; Khan, K; Lewis, A; Massard, C; Maynard, A; McKenzie, H; Michielin, O; Mosenthal, AC; Obispo, B; Palmieri, C; Patel, R; Pentheroudakis, G; Peters, S; Rieger-Christ, K; Robinson, T; Romano, E; Rowe, M; Sekacheva, M; Sheehan, R; Stockdale, A; Thomas, A; Turtle, L; Vinal, D; Weaver, J; Williams, S; Wilson, C; Dive, C; Landers, D; Cooksley, T; Freitas, A; Armstrong, AC; Lee, RJ.

An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves

Cancers. 2022; 14(16): Nº de citas: 2 [doi:10.3390/cancers14163931]

Martin-Roman, L; Fernandez-Martinez, M; Kayser Mata, S; Colombari, R; Pascual-Espinosa, P; Rey-Valcarcel, C; Jimenez-Gomez, LM; Turegano-Fuentes, F.

Relevance of pneumoperitoneum in the conservative approach to complicated acute diverticulitis A retrospective study identifying risk factors associated with treatment failure

Minerva Surgery. 2022; 77(4): 327-334 Nº de citas: 6 [doi:10.23736/S2724-5691.21.08997-8]

Gil-Herrero, L; Pollan, M; Martin, M; Lopez-Tarruella, S; Castellanos, M; Casla-Barrio, S.

The importance of physical exercise in cardiovascular fitness in breast cancer survivors. A cross-sectional study: women in Motion 2.0

SUPPORTIVE CARE IN CANCER. 2022; 30(8): 6745-6754 Nº de citas: 9 [doi:10.1007/s00520-022-06993-9]

Martin, M; Hegg, R; Kim, SB; Schenker, M; Grecea, D; Garcia-Saenz, JA; Papazisis, K; Ouyang, QC; Lacko, A; Oksuzoglu, B; Reeves, J; Okera, M; Testa, L; Shimizu, C; Denduluri, N; Adamchuk, H; Dakhil, S; Wei, R; Forrester, T; Fernandez, MM; Zimmermann, A; Headley, D; Johnston, SRD.

Treatment With Adjuvant Abemaciclib Plus Endocrine Therapy in Patients With High-risk Early Breast Cancer Who Received Neoadjuvant Chemotherapy A Prespecified Analysis of the monarchE Randomized Clinical Trial

JAMA Oncology. 2022; 8(8): 1190-1194 Nº de citas: 49 [doi:10.1001/jamaoncol.2022.1488]

Hamilton, E; Cortes, J; Ozyilkan, O; Chen, SC; Petrakova, K; Manikhas, A; Jerusalem, G; Hegg, R; Huober, J; Zhang, W; Chen, YY; Martin, M.

nextMONARCH Phase 2 randomized clinical trial: overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with endocrine-refractory HR +, HER2-metastatic breast cancer

BREAST CANCER RESEARCH AND TREATMENT. 2022; 195(1): 55-64 Nº de citas: 19 [doi:10.1007/s10549-022-06662-9]

Escudero-Vilaplana, V; Romero-Medrano, L; Villanueva-Bueno, C; de Diago, MR; Yanez-Montesdeoca, A; Collado-Borrell, R; Campana-Montes, JJ; Marzal-Alfaro, B; Revuelta-Herrero, JL; Calles, A; Galera, M; Alvarez, R; Herranz, A; Sanjurjo, M; Artes-Rodriguez, A.

Smartphone-Based Ecological Momentary Assessment for the Measurement of the Performance Status and Health-Related Quality of Life in Cancer Patients Under Systemic Anticancer Therapies: Development and Acceptability of a Mobile App

Frontiers in Oncology. 2022; 12: [doi:10.3389/fonc.2022.880430]

Farge, D; Frere, C; Connors, JM; Khorana, AA; Kakkar, A; Ay, C; Munoz, A; Brenner, B; Prata, PH; Brilhante, D; Antic, D; Casais, P; Esposito, MCG; Ikezoe, T; Abutalib, SA; Meillon-Garcia, LA; Bounameaux, H; Pabinger, I; Douketis, J.

2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19

LANCET ONCOLOGY. 2022; 23(7): 334-347 Nº de citas: 340

Vicente-Valor, J; Escudero-Vilaplana, V; Collado-Borrell, R; Lopez-Lopez, C; Villanueva-Bueno, C; Revuelta-Herrero, JL; Ruiz-Briones, P; Somoza-Fernandez, B; Herranz, A; Sanjurjo, M.

Potential negative pharmacodynamic interaction of spironolactone and abiraterone in two prostate cancer patients

JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2022; 28(5): 1259-1263 Nº de citas: 5 [doi:10.1177/10781552221074621]

Santonja Á; Moya-García AA; Ribelles N; Jiménez-Rodríguez B; Pajares B; Fernández-De Sousa CE; Pérez-Ruiz E; Del Monte-Millán M; Ruiz-Borrego M; de la Haba J; Sánchez-Rovira P; Romero A; González-Neira A; Lluch A; Alba E.

Role of germline variants in the metastasis of breast carcinomas.

Oncotarget. 2022; 13: 843-862 Nº de citas: 1 [doi:10.18632/oncotarget.28250]

Chauhan, J; Aasaithambi, S; Marquez-Rodas, I; Formisano, L; Papa, S; Meyer, N; Forschner, A; Faust, G; Lau, M; Sagkriotis, A.

Understanding the Lived Experiences of Patients With Melanoma: Real-World Evidence Generated Through a European Social Media Listening Analysis

JMIR Cancer. 2022; 8(2): Nº de citas: 10 [doi:10.2196/35930]

Garcia-Sanchez, S; Collado-Borrell, R; Gonzalez-Haba, E; Revuelta-Herrero, JL; Escudero-Vilaplana, V; Marzal-Alfaro, MB; Sanchez-Fresneda, MN; Mur-Mur, A; Herranz, A; Martin, M; Sanjurjo, M.

A New Methodology to Estimate Drug Cost Avoidance in Clinical Trials: Development and Application

Frontiers in Oncology. 2022; 12: Nº de citas: 5 [doi:10.3389/fonc.2022.889575]

Pacheco-Barcia, V; Munoz, A; Castro, E; Ballesteros, AI; Marquina, G; Gonzalez-Diaz, I; Colomer, R; Romero-Laorden, N.

The Homologous Recombination Deficiency Scar in Advanced Cancer: Agnostic Targeting of Damaged DNA Repair

Cancers. 2022; 14(12): Nº de citas: 21 [doi:10.3390/cancers14122950]

Kopetz, S; Grothey, A; Van Cutsem, E; Yaeger, R; Wasan, H; Yoshino, T; Desai, J; Ciardiello, F; Loupakis, F; Hong, YS; Steeghs, N; Guren, TK; Arkenau, HT; Garcia-Alfonso, P; Belani, A; Zhang, X; Tabernero, J.

Quality of life with encorafenib plus cetuximab with or without binimetinib treatment in patients with BRAF V600E-mutant metastatic colorectal cancer: patient-reported outcomes from BEACON CRC

ESMO Open. 2022; 7(3): Nº de citas: 18 [doi:10.1016/j.esmoop.2022.100477]

Bellmunt, J; Valderrama, BP; Puente, J; Grande, E; Bolos, MV; Lainez, N; Vazquez, S; Maroto, P; Climent, MA; del Muro, XG; Arranz, JA; Duran, I.

Recent therapeutic advances in urothelial carcinoma: A paradigm shift in disease management

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2022; 174: Nº de citas: 24 [doi:10.1016/j.critrevonc.2022.103683]